Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study

Myung-Ju Ahn, Filippo de Marinis, Byoung Chul Cho, Tae Min Kim, Susanna Cheng, Silvia Novello, Claudia Proto, Sang-We Kim, Jong Seok Lee, Giulio Metro, Lecia V. Sequist, James Chih-Hsin Yang, Wanning Xu, Aino Telaranta-Keerie, Alexander Todd, Gina D'Angelo, Ryan Hartmaier, Laura Bonanno

Open source

DOI: 10.1158/1078-0432.ccr-26-0604
Published: 2026-09-17
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-0604,
  title = {Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study},
  author = {Myung-Ju Ahn and Filippo de Marinis and Byoung Chul Cho and Tae Min Kim and Susanna Cheng and Silvia Novello and Claudia Proto and Sang-We Kim and Jong Seok Lee and Giulio Metro and Lecia V. Sequist and James Chih-Hsin Yang and Wanning Xu and Aino Telaranta-Keerie and Alexander Todd and Gina D'Angelo and Ryan Hartmaier and Laura Bonanno},
  year = {2026},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-0604},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-0604}
}

RIS

TY  - JOUR
TI  - Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study
AU  - Myung-Ju Ahn
AU  - Filippo de Marinis
AU  - Byoung Chul Cho
AU  - Tae Min Kim
AU  - Susanna Cheng
AU  - Silvia Novello
AU  - Claudia Proto
AU  - Sang-We Kim
AU  - Jong Seok Lee
AU  - Giulio Metro
AU  - Lecia V. Sequist
AU  - James Chih-Hsin Yang
AU  - Wanning Xu
AU  - Aino Telaranta-Keerie
AU  - Alexander Todd
AU  - Gina D'Angelo
AU  - Ryan Hartmaier
AU  - Laura Bonanno
PY  - 2026
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-26-0604
UR  - https://doi.org/10.1158/1078-0432.ccr-26-0604
ER  -

APA

Ahn, M., Marinis, F. D., Cho, B. C., Kim, T. M., Cheng, S., Novello, S., Proto, C., Kim, S., Lee, J. S., Metro, G., Sequist, L. V., Yang, J. C., Xu, W., Telaranta-Keerie, A., Todd, A., D'Angelo, G., Hartmaier, R., & Bonanno, L. (2026). Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-0604

Source records

crossref · retrieved 2026-09-26T06:13:12.479Z